INVO reports Q3 2026 earnings with record clinic revenues
INVO reported third quarter 2026 financial results highlighting 28% clinic revenue growth, a narrowing net loss, and a strengthened balance sheet driven by acquisitions and debt repayments.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed